Konga Health, LivFul collaborate for Akiva™ a next generation Anti-Mosquito Lotion

Konga Healthcare, the pioneering digital healthcare distribution company and LivFul, Inc. have joined forces in unveiling a cutting-edge product that combats insect bites to the Nigerian market.

This strategic partnership brings Akiva™, a next-generation insect repellent, to the Nigerian market.

Thanks to LivFul’s patented STAYTEC™ technology, Akiva™ is specifically designed to control the evaporation and limit the absorption of the active repelling ingredients into the skin, giving long lasting protection from insect bites for 14 hours, and allowing individuals to enjoy their day without the irritation of bites. The exceptional safety profile of the anti-mosquito lotion means that it is safe

to use for pregnant and breastfeeding women, as well as children from 2 months old.

The key features that sets Akiva™ apart is its emphasis on user experience. As an Anti-Mosquito lotion, Akiva™ not only offers unparalleled protection but also allows individuals to go about their daily activities without the discomfort of sticky or greasy skin.

This model completely aligns with Konga Health’s dedication to providing customers with products that improve their quality of life.

Furthermore, LivFul’s collaboration with Konga Health signifies a paradigm shift in how insect repellents are perceived. It emphasizes the importance of daily proactive measures to prevent insect bites rather than merely addressing the consequences. By promoting awareness about the significance of skin-friendly repellents that can be used safely on a daily basis, this partnership encourages a holistic approach to personal health, urging individuals to prioritize prevention and well-being.

Do you have a compelling story to tell? Contact us via our email: espinewsng@gmail.com or call/WhatsApp on 08032519246.